AVXL - Anavex Life Sciences GAAP EPS of -$0.11 beats by $0.04
2024-02-07 07:35:23 ET
More on Anavex Life Sciences
- Anavex: The Pediatric Rett Trial Failure Is Disastrous
- How Soon Might Anavex's Alzheimer's Drug Be Approved? The Good/Bad News
- Anavex Life Sciences: Rett Safety Dance With Broader CNS Implications (Rating Downgrade)
- Anavex drops as Phase 2/3 trial for Rett syndrome candidate fails
- Anavex gets EMA green light to submit blarcamesine application for Alzheimer's